Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Atpenin A5 (synthetic)

Mitochondrial complex II inhibitor
 
ALX-380-313-MC25 0.25 mg 114.00 USD
 
ALX-380-313-M001 1 mg 365.00 USD
Do you need bulk/larger quantities?
 
Replaces Prod. #: ALX-380-108

Antibiotic. Potent and specific inhibitor of mitochondrial complex II (succinate-ubiquinone oxidoreductase).

Product Specification

Alternative Name:3-[(2S,4S,5R)-5,6-Dichloro-2,4-dimethyl-1-oxohexyl]-4-hydroxy-5,6-dimethoxy-2(1H)-pyridinone
 
Formula:C15H21Cl2NO5
 
MW:366.2
 
Source:Synthetic. Originally isolated from Penicillium sp. strain FO-125.
 
CAS:119509-24-9
 
RTECS:CJ8800000
 
Purity:≥95% (HPLC)
 
Appearance:White to off-white powder.
 
Solubility:Soluble in acetone, acetonitrile, chloroform, ethyl acetate, DMSO, methanol or 100% ethanol; insoluble in water or hexane.
 
Shipping:Ambient
 
Long Term Storage:-20°C
 
Technical Info/Product Notes:The IC50 value against bovine heart complex II is 3.6nM (which is ~300-fold lower than the IC50 value of carboxin (1.1μM)). It also inhibits fumarate reductase of Ascaris suum (IC50 = 12nM). Inhibition of E. coli succinate dehydrogenase is less potent (IC50 = 5μM).By co-crystallization studies of atpenin A5 and complex II, the binding site of atpenin A5 was found to be the quinone-binding site of complex II. Additionally, atpenin A5 has been shown to have a protective action against ischemia-reperfusion via the activation of mitochondrial KATP channels.
 
380-108
Please mouse over
380-108

Product Literature References

Dual loss of succinate dehydrogenase (SDH) and complex I activity is necessary to recapitulate the metabolic phenotype of SDH mutant tumors: D. Lorendeau, et al.; Metab. Eng. (2016), Abstract;
Ubiquinone-binding site mutagenesis reveals the role of mitochondrial complex II in cell death initiation: K. Kluckova, et al.; Cell Death Dis. 6, e1749 (2015), Application(s): Cell Culture, Abstract; Full Text
Enantioselective total synthesis of atpenin A5: M. Ohtawa et al.; J. Antibiot. 62, 289 (2009), Abstract;
The complex II inhibitor atpenin A5 protects against cardiac ischemia-reperfusion injury via activation of mitochondrial KATP channels: A. P. Wojtovich & P. S. Brooks; Basic Res. Cardiol. 104, 121 (2009), Abstract;
Structural and computational analysis of the quinone-binding site of complex II (succinate-ubiquinone oxidoreductase): a mechanism of electron transfer and proton conduction during ubiquinone reduction: R. Horsefield, et al.; J. Biol. Chem. 281, 7309 (2006), Abstract; Full Text
Atpenins, potent and specific inhibitors of mitochondrial complex II (succinate-ubiquinone oxidoreductase): H. Miyadera, et al.; PNAS 100, 473 (2003), Abstract;
Mechanism of action of atpenin B on Raji cells: K. Oshino, et al.; J. Antibiot. 43, 1064 (1990), Abstract;
The structures of atpenins A4, A5 and B, new antifungal antibiotics produced by Penicillium sp: H. Kumagai, et al.; J. Antibiot. 43, 1553 (1990), Abstract;
Atpenins, new antifungal antibiotics produced by Penicillium sp. Production, isolation, physico-chemical and biological properties: S. Omura, et al.; J. Antibiot. 41, 1769 (1988), Abstract;

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,